Aplastic Anemia Complicating Sjögren's Syndrome

Internal Medicine

Volumn 36, Issue 5, 1997, Pages 371-374

  Matsumoto, Noriaki ^a   Kagawa, Hideo ^a   Ichiyoshi, Hiroshi ^a   Iguchi, Tomoko ^a   Yamanaka, Yoshitaka ^a   Kishimoto, Yuji ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Immunosuppressive therapy; Pancytopenia; Polyclonal gammopathy

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

APLASTIC ANEMIA; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; MIDDLE AGED; SJOEGREN SYNDROME;

ANEMIA, APLASTIC; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 0031133405     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.371     Document Type: Article

References (14)

1. Moutsopoulos HM, Chused TM, Mann DL, el al. Sjögren's syndrome (sicca syndrome). Ann Intern Med 92: 212, 1908.
2. Seki T, Kiyosawa K, Monno S, et al. Cell-mediated immune-pancytopenia complicating primary Sjögren's syndrome. Am J Hematol 43: 221, 1993.
3. Satoh M, Yamagata F, Watanabe F, et al. A case of Sjögren's syndrome complicating immune-mediated aplastic anaemia. Clin Rheumatol 12: 257, 1993.
4. Yoshida H, Wakashin M, Okuda K. Successful treatment of aplastic anemia associated with chronic thyroiditis and Sjögren's syndrome (letter). J Rheumatol 13: 1189, 1986.
5. Fitchen JJ, Cline MJ, Saxon A. Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. Am J Med 66: 537, 1979.
6. Bailey FA, Lilly M, Bertoli LF, Ball GV. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 32: 901, 1989.
7. Brooks BJ Jr, Broxmeyer HE, Bryan CF, Leech SH. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Intern Med 144: 1474, 1984.
8. Talal N, Bunim JJ. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 36: 529, 1964.
9. Nagai K. Sjögren's syndrome associated with non Hodgkin's lymphoma. Nippon Rinsho 53: 2574, 1995.
10. Camitta BM, Storb R, Thomas ED. Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306: 645, 1982.
11. Piaggio G, Bacigalupo A, Frassoni F, et al. T-derived colony-inhibiting activity. Partial characterization and mechanism of action. Acta Haematol 74: 195, 1985.
12. Tong J, Bacigalupo A, Piaggio G. Figari O, Sogno G, Marmont A. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin: Colony-stimulating activity and lyphokine production. Exp Hematol 19: 312, 1991.
13. Teramura M, Saito H, Kobayashi S, Hosino S, Oshimi K, Mizoguchi H. Mechanism of immunosuppressive therapy for aplastic anemia. Rinsho Ketsueki 34: 273, 1993.
14. Fye KH, Daniels TE, Zulman J, et al. Aplastic anemia and lymphoma in Sjögren's syndrome. Arthritis Rheum 23: 1321, 1980.